Literature DB >> 14705880

Grape polyphenol resveratrol and the related molecule 4-hydroxystilbene induce growth inhibition, apoptosis, S-phase arrest, and upregulation of cyclins A, E, and B1 in human SK-Mel-28 melanoma cells.

Mar Larrosa1, Francisco A Tomás-Barberán, Juan Carlos Espín.   

Abstract

The effect of the naturally occurring polyphenol resveratrol (3,5,4'-trihydroxy-trans-stilbene; RES) on growth, cell cycle, and cyclins A, E, and B1 expression was investigated in the human SK-Mel-28 melanoma cell line. In addition, the structurally related compounds 4-hydroxy-trans-stilbene (4HST), piceatannol (3,5,3',4'-tetrahydroxy-trans-stilbene (PICE), and 4-trans-stilbenemethanol (4STMe) were also assayed in order to investigate the requirements of stilbenes to exert activity against melanoma cells. Both RES and 4HST inhibited cell growth in a dose- and time-dependent manner and upregulated the expression of cyclins A, E, and B1 with subsequent irreversible arrest of melanoma cells in the S-phase, concomitant with a decrease in G0/G1 and G2/M phases. In addition, potent apoptosis-mediated cell death was detected with the annexin V assay whereas no apoptosis was observed by flow cytometry, which encourages the assay of different methodologies to evaluate the effect of polyphenols on cell lines. The effect of PICE was not evaluated because of its instability in the reaction medium. No effect on cell cycle and cyclins expression was observed when 4STMe was assayed, which supported the critical requirement of the 4'-hydroxystyryl moiety to exert the above effects. In addition, this structural requirement also influenced the cellular uptake of stilbenes. The presence of two extra hydroxyl groups in RES increased its cytotoxicity whereas it diminished its efficiency to inhibit cell growth, upregulate cyclins expression, and arrest cell cycle in the S-phase with respect to 4HST. The present study suggests that the antimelanoma properties of dietary stilbenes, such as grape RES, cannot be ruled out, taking into account previous studies concerning the relationship between plasma and tissue concentrations and pharmacological activity of RES in animal models.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14705880     DOI: 10.1021/jf030073c

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  21 in total

Review 1.  Use of Polyphenolic Compounds in Dermatologic Oncology.

Authors:  Adilson Costa; Michael Yi Bonner; Jack L Arbiser
Journal:  Am J Clin Dermatol       Date:  2016-08       Impact factor: 7.403

2.  The stilbenoid tyrosine kinase inhibitor, G6, suppresses Jak2-V617F-mediated human pathological cell growth in vitro and in vivo.

Authors:  Annet Kirabo; Jennifer Embury; Róbert Kiss; Tímea Polgár; Meghanath Gali; Anurima Majumder; Kirpal S Bisht; Christopher R Cogle; György M Keseru; Peter P Sayeski
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

3.  The Jak2 inhibitor, G6, alleviates Jak2-V617F-mediated myeloproliferative neoplasia by providing significant therapeutic efficacy to the bone marrow.

Authors:  Annet Kirabo; Sung O Park; Anurima Majumder; Meghanath Gali; Mary K Reinhard; Heather L Wamsley; Zhizhuang Joe Zhao; Christopher R Cogle; Kirpal S Bisht; György M Keserü; Peter P Sayeski
Journal:  Neoplasia       Date:  2011-11       Impact factor: 5.715

4.  Resveratrol inhibits cell growth and induces apoptosis of rat C6 glioma cells.

Authors:  Wei Zhang; Zhou Fei; Hai-Ning Zhen; Jian-Ning Zhang; Xiang Zhang
Journal:  J Neurooncol       Date:  2006-09-20       Impact factor: 4.130

Review 5.  Phytochemicals for the Management of Melanoma.

Authors:  Harish Chandra Pal; Katherine Marchiony Hunt; Ariana Diamond; Craig A Elmets; Farrukh Afaq
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

Review 6.  Botanicals for the prevention and treatment of cutaneous melanoma.

Authors:  Deeba N Syed; Hasan Mukhtar
Journal:  Pigment Cell Melanoma Res       Date:  2011-04-12       Impact factor: 4.693

7.  Boron uptake in normal melanocytes and melanoma cells and boron biodistribution study in mice bearing B16F10 melanoma for boron neutron capture therapy.

Authors:  Fernanda Faião-Flores; Paulo Rogério Pinto Coelho; João Dias Toledo Arruda-Neto; Maria Aparecida Pires Camillo; Silvya Stuchi Maria-Engler; Rose Eli Grassi Rici; Jorge Eduardo Souza Sarkis; Durvanei Augusto Maria
Journal:  Radiat Environ Biophys       Date:  2012-04-11       Impact factor: 1.925

8.  Piceatannol alleviates glucolipotoxicity induced vascular barrier injury through inhibition of the ROS/NF-kappa B signaling pathway.

Authors:  Zhen Wang; Yun-Long Lu; Miao Chen; Hong-Fei Xu; Liang-Rong Zheng
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

9.  The grape and wine polyphenol piceatannol is a potent inducer of apoptosis in human SK-Mel-28 melanoma cells.

Authors:  Mar Larrosa; Francisco A Tomás-Barberán; Juan Carlos Espín
Journal:  Eur J Nutr       Date:  2004-01-12       Impact factor: 5.614

10.  The small molecule inhibitor G6 significantly reduces bone marrow fibrosis and the mutant burden in a mouse model of Jak2-mediated myelofibrosis.

Authors:  Annet Kirabo; Sung O Park; Heather L Wamsley; Meghanath Gali; Rebekah Baskin; Mary K Reinhard; Zhizhuang J Zhao; Kirpal S Bisht; György M Keserű; Christopher R Cogle; Peter P Sayeski
Journal:  Am J Pathol       Date:  2012-07-13       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.